| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,362 |
7,316 |
$1.36M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,868 |
4,159 |
$1.03M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,552 |
1,274 |
$380K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,860 |
1,597 |
$195K |
| 70450 |
Computed tomography, head or brain; without contrast material |
256 |
218 |
$111K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,502 |
1,133 |
$103K |
| 80053 |
Comprehensive metabolic panel |
11,853 |
9,178 |
$83K |
| 71045 |
Radiologic examination, chest; single view |
1,317 |
1,017 |
$73K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,338 |
9,662 |
$68K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,382 |
1,831 |
$66K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
806 |
594 |
$50K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
51 |
41 |
$41K |
| 71046 |
Radiologic examination, chest; 2 views |
438 |
372 |
$38K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
762 |
638 |
$33K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
226 |
194 |
$24K |
| 36415 |
Collection of venous blood by venipuncture |
10,766 |
8,269 |
$20K |
| 87428 |
|
751 |
597 |
$17K |
| 87400 |
|
1,327 |
748 |
$17K |
| 80061 |
Lipid panel |
1,467 |
1,349 |
$16K |
| J3490 |
Unclassified drugs |
443 |
261 |
$14K |
| 87430 |
|
1,234 |
1,100 |
$10K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
152 |
106 |
$10K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
352 |
294 |
$9K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
568 |
472 |
$9K |
| G0378 |
Hospital observation service, per hour |
81 |
53 |
$8K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
68 |
59 |
$7K |
| 84484 |
|
1,034 |
670 |
$7K |
| 81025 |
|
922 |
807 |
$6K |
| 82728 |
|
586 |
495 |
$6K |
| 82553 |
|
1,072 |
647 |
$6K |
| 80050 |
General health panel |
126 |
123 |
$5K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
70 |
69 |
$5K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
158 |
137 |
$5K |
| 82550 |
|
1,330 |
842 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
561 |
519 |
$4K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
120 |
65 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
279 |
243 |
$4K |
| 83550 |
|
567 |
484 |
$4K |
| 0001A |
|
93 |
79 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
92 |
84 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
86 |
44 |
$3K |
| 0002A |
|
79 |
70 |
$3K |
| 83880 |
|
252 |
161 |
$3K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
231 |
171 |
$3K |
| 83540 |
|
585 |
496 |
$3K |
| 0012A |
|
87 |
71 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
366 |
313 |
$2K |
| 74018 |
|
28 |
25 |
$2K |
| 81003 |
|
1,401 |
1,140 |
$2K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
31 |
26 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
36 |
13 |
$2K |
| 86003 |
|
12 |
12 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
66 |
63 |
$2K |
| 0011A |
|
70 |
49 |
$1K |
| 81001 |
|
608 |
496 |
$1K |
| 0013A |
|
33 |
31 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
77 |
41 |
$917.13 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
71 |
46 |
$746.61 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
21 |
14 |
$641.35 |
| 74021 |
|
15 |
12 |
$624.94 |
| 83735 |
|
198 |
149 |
$609.88 |
| 82607 |
|
43 |
40 |
$588.77 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
114 |
91 |
$579.17 |
| 84439 |
|
76 |
73 |
$569.03 |
| 86308 |
|
90 |
83 |
$537.21 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
30 |
25 |
$535.66 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
12 |
12 |
$519.96 |
| 83690 |
|
85 |
74 |
$475.15 |
| 86677 |
|
50 |
42 |
$474.60 |
| 82746 |
|
29 |
28 |
$427.05 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
14 |
13 |
$423.56 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
14 |
13 |
$423.56 |
| 86140 |
|
103 |
99 |
$398.99 |
| 0031A |
|
19 |
13 |
$366.54 |
| 82248 |
|
76 |
71 |
$302.72 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
534 |
393 |
$232.86 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
575 |
187 |
$218.55 |
| 82150 |
|
34 |
28 |
$198.56 |
| 87070 |
|
15 |
14 |
$143.61 |
| 85730 |
|
52 |
46 |
$130.70 |
| 85610 |
|
73 |
62 |
$116.48 |
| 90461 |
|
145 |
88 |
$95.36 |
| 87088 |
|
20 |
12 |
$95.06 |
| 85379 |
|
13 |
12 |
$82.87 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,204 |
972 |
$74.75 |
| 83615 |
|
14 |
12 |
$54.36 |
| 85018 |
|
124 |
87 |
$52.14 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12 |
12 |
$45.45 |
| 87118 |
|
18 |
12 |
$39.20 |
| 91301 |
|
273 |
229 |
$21.54 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,141 |
493 |
$21.00 |
| 84134 |
|
24 |
24 |
$7.59 |
| 91300 |
|
231 |
178 |
$0.08 |
| T1015 |
Clinic visit/encounter, all-inclusive |
2,101 |
1,542 |
$0.00 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
288 |
227 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
15 |
12 |
$0.00 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
52 |
30 |
$0.00 |
| 87420 |
|
31 |
25 |
$0.00 |
| 80320 |
|
15 |
12 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
91 |
82 |
$0.00 |